Screener Valuation Movers Economy Bonds Institutions Business Summaries Updates

Screener Summaries Updates Institutions

All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.

Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.

About Privacy Policy Terms of Service Contact

© 2026 go-intrinsic.com. All rights reserved.

Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Genmab A/S (GNMSF)

Pharmaceutical Preparations

Latest Price

--

TTM P/E

--

Normalized P/E

--

TTM Div Yield

--

Fwd Div Yield

--

Book Value

--

P/B Ratio

--

Valuation metrics

adjust assumptions →

EPS: $15.37

Book value / share: $91.02

Formula: √(22.5 × EPS × BVPS)

Graham Number

$177.42

Norm. op. income: $5.3B (median of 7yr)

Tax rate: 22%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$676.87

EPS: $15.37

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$230.55